178 related articles for article (PubMed ID: 3140032)
1. The costs of crime and the benefits of drug abuse treatment: a cost-benefit analysis using TOPS data.
Harwood HJ; Hubbard RL; Collins JJ; Rachal JV
NIDA Res Monogr; 1988; 86():209-35. PubMed ID: 3140032
[No Abstract] [Full Text] [Related]
2. The criminal justice client in drug abuse treatment.
Hubbard RL; Collins JJ; Rachal JV; Cavanaugh ER
NIDA Res Monogr; 1988; 86():57-80. PubMed ID: 3140035
[No Abstract] [Full Text] [Related]
3. Guidelines and challenges for estimating the economic costs and benefits of adolescent substance abuse treatments.
Zavala SK; French MT; Henderson CE; Alberga L; Rowe C; Liddle HA
J Subst Abuse Treat; 2005 Oct; 29(3):191-205. PubMed ID: 16183468
[TBL] [Abstract][Full Text] [Related]
4. Compulsory treatment: a review of findings.
Leukefeld CG; Tims FM
NIDA Res Monogr; 1988; 86():236-51. PubMed ID: 3140033
[No Abstract] [Full Text] [Related]
5. Economic benefits of substance abuse treatment: findings from Cuyahoga County, Ohio.
Koenig L; Siegel JM; Harwood H; Gilani J; Chen YJ; Leahy P; Stephens R
J Subst Abuse Treat; 2005; 28 Suppl 1():S41-50. PubMed ID: 15797638
[TBL] [Abstract][Full Text] [Related]
6. Reductions in criminal convictions after addiction treatment: 5-year follow-up.
Gossop M; Trakada K; Stewart D; Witton J
Drug Alcohol Depend; 2005 Sep; 79(3):295-302. PubMed ID: 16102373
[TBL] [Abstract][Full Text] [Related]
7. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
Woodward AM; Raskin IE; Blacklow B
Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082
[TBL] [Abstract][Full Text] [Related]
8. Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS).
Godfrey C; Stewart D; Gossop M
Addiction; 2004 Jun; 99(6):697-707. PubMed ID: 15139868
[TBL] [Abstract][Full Text] [Related]
9. Organizational and client determinants of cost in outpatient substance abuse treatment.
Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
[TBL] [Abstract][Full Text] [Related]
10. Treatment alternatives to street crime.
Cook LF; Weinman BA
NIDA Res Monogr; 1988; 86():99-105. PubMed ID: 3140038
[TBL] [Abstract][Full Text] [Related]
11. National study of drug abuse treatment finds benefits include less drug use, fewer crimes.
Hosp Community Psychiatry; 1989 Dec; 40(12):1309-10. PubMed ID: 2512243
[No Abstract] [Full Text] [Related]
12. Cost-effectiveness of alcohol and drug treatment programs.
Caldwel JR
J Fla Med Assoc; 1993 Jun; 80(6):385-6. PubMed ID: 8340771
[No Abstract] [Full Text] [Related]
13. A cost-effectiveness model for evaluating health care programs: application to drug abuse treatment.
Goldschmidt PG
Inquiry; 1976 Mar; 13(1):29-47. PubMed ID: 130347
[No Abstract] [Full Text] [Related]
14. Substance abuse, treatment, and the courts. Alcohol and drug abuse contributing factor in 80% of U.S. crimes.
J Psychosoc Nurs Ment Health Serv; 1997 Jul; 35(7):8-9. PubMed ID: 9243416
[No Abstract] [Full Text] [Related]
15. The nature and status of drug abuse treatment.
Nurco DN; Kinlock TW; Hanlon TE
Md Med J; 1994 Jan; 43(1):51-7. PubMed ID: 8183085
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
[TBL] [Abstract][Full Text] [Related]
17. The costs of pursuing accreditation for methadone treatment sites: results from a national study.
Zarkin GA; Dunlap LJ; Homsi G
Eval Rev; 2006 Apr; 30(2):119-38. PubMed ID: 16492995
[TBL] [Abstract][Full Text] [Related]
18. Socioeconomic analysis of addictions treatment.
Langenbucher JW
Public Health Rep; 1996; 111(2):135-7. PubMed ID: 8606910
[No Abstract] [Full Text] [Related]
19. Legal status and long-term outcomes for addicts in the DARP followup project.
Simpson DD; Friend HJ
NIDA Res Monogr; 1988; 86():81-98. PubMed ID: 3140037
[No Abstract] [Full Text] [Related]
20. Cost-effectiveness of drug abuse treatment: relevant issues and alternative longitudinal modeling approaches.
Hser YI; Anglin MD
NIDA Res Monogr; 1991; 113():67-93. PubMed ID: 1762644
[No Abstract] [Full Text] [Related]
[Next] [New Search]
